高达15%的病人认为流行药物的重量减幅很小,这突出表明需要个性化肥胖症治疗计划。 Up to 15% of patients see little weight loss with popular drugs, highlighting the need for personalized obesity treatment plans.

尽管像Ozempic和Wegovy这样的减重药物很受欢迎,在临床试验中,多达15%的病人减重最少。 Despite the popularity of weight-loss drugs like Ozempic and Wegovy, up to 15% of patients in clinical trials have seen minimal weight loss. 医疗条件、其他药物和个别对策等因素可能影响药物的有效性。 Factors such as medical conditions, other medications, and individual responses can affect the drugs' effectiveness. 医生们建议尝试不同版本的药物、老年药物或改变饮食、锻炼、睡眠和压力习惯,以取得更好的结果。 Doctors recommend trying different versions of the drugs, older medications, or altering diet, exercise, sleep, and stress habits for better outcomes. 肥胖症治疗应是全面的,并适合每个患者的需要。 Obesity treatment should be comprehensive and tailored to each patient.